By Counterforce Health Team in Mavenclad (cladribine tablets) —

How to Get Mavenclad (Cladribine Tablets) Covered by Aetna CVS Health in Virginia: Complete Appeals Guide

Answer Box: Your Path to Mavenclad Coverage in Virginia

To get Mavenclad (cladribine tablets) covered by Aetna CVS Health in Virginia: Your neurologist must submit prior authorization showing you have relapsing MS, failed at least two other DMTs, and meet lab requirements (lymphocyte count ≥800 cells/μL). If denied, you have 180 days to appeal internally, then can request external review through Virginia's State Corporation Commission within 120 days. Virginia law requires step therapy exceptions within 72 hours if you've failed preferred drugs or they're contraindicated.

Start today: Contact your neurologist to gather documentation of prior DMT failures and recent lab results for the PA submission.

Table of Contents

Virginia's Insurance Protections for MS Patients

Virginia has strengthened patient protections significantly since expanding Medicaid in 2019, with the uninsured rate dropping to just 6.4% in 2023. For specialty medications like Mavenclad, Virginia law provides specific safeguards that work alongside your Aetna CVS Health plan policies.

Key Virginia protections include:

  • 72-hour step therapy override decisions for medically necessary exceptions
  • External review through the State Corporation Commission within 120 days of final denial
  • Expedited appeals (24-72 hours) for urgent medical situations
  • No-cost external review process with independent medical experts
Note: These protections apply to Virginia-regulated plans. Self-funded employer plans may opt into Virginia's external review process but aren't required to follow all state rules.

Aetna CVS Health Prior Authorization Requirements

Aetna CVS Health requires comprehensive documentation for Mavenclad approval. Based on their current prior authorization criteria, you'll need:

Coverage at a Glance

Requirement What It Means Documentation Needed
Diagnosis Relapsing forms of MS only ICD-10 code G35, MRI reports
Prior Failures At least 2 other DMTs tried Names, dates, reasons for stopping
Lab Requirements Lymphocyte count ≥800 cells/μL CBC within 3 months
Prescriber Must be neurologist NPI number, specialty credentials
Contraception For women of childbearing age Documentation of reliable method

Medical Necessity Documentation

Your neurologist's letter must include:

  • MS diagnosis confirmation with imaging evidence
  • Detailed history of prior DMTs including specific drugs, durations, and outcomes
  • Clinical rationale for why Mavenclad is uniquely appropriate
  • Safety screening showing no active infections, malignancy, or pregnancy
  • Monitoring plan for lymphocyte counts during treatment

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient + Clinic)

  • Insurance card and member ID
  • Complete MS treatment history
  • Recent labs (CBC with differential within 3 months)
  • MRI reports confirming MS diagnosis
  • Timeline: 1-2 days

2. Neurologist Completes PA Request (Clinic)

  • Submit via CVS Caremark provider portal or fax to 1-888-267-3277
  • Include comprehensive medical necessity letter
  • Timeline: 72 hours for standard decision

3. Follow Up if No Response (Patient + Clinic)

  • Contact Aetna member services to confirm receipt
  • Virginia law considers delayed responses as approvals
  • Timeline: Within 5 business days of submission

4. If Denied, Request Peer-to-Peer (Clinic)

  • Neurologist speaks directly with Aetna medical director
  • Often resolves complex cases without formal appeal
  • Timeline: Within 48 hours of denial

5. File Internal Appeal if Needed (Patient)

  • Submit within 180 days of denial notice
  • Include additional clinical evidence
  • Timeline: 30-45 days for decision

6. External Review Through Virginia SCC (Patient)

  • File Form 216-A within 120 days
  • Independent medical review by specialists
  • Timeline: 45 days for standard, 72 hours for expedited

Virginia Step Therapy Override Rights

Virginia's step therapy law (§38.2-3407.9:05) requires Aetna to grant exceptions within 72 hours when your neurologist documents:

  • Contraindication: The preferred drug would be harmful
  • Ineffectiveness: Based on your clinical characteristics
  • Prior failure: You've tried and stopped the preferred drug due to lack of efficacy or side effects
  • Current stability: You're doing well on your current treatment

Sample Documentation Language

When requesting a step therapy override, your neurologist should state:

"Patient has previously failed [specific DMT] due to [specific reason - lack of efficacy/adverse effects] as documented in medical record from [date]. Per Virginia Code §38.2-3407.9:05, this constitutes grounds for step therapy exception approval within 72 hours."

Appeals Process: Internal to External Review

Internal Appeals (Aetna CVS Health)

  • Deadline: 180 days from denial notice
  • Timeline: 30-45 days for standard, 72 hours for expedited
  • How to file: Online portal or written request to address on denial letter
  • Required: Copy of denial letter, additional medical evidence, member statement

External Review (Virginia SCC)

After exhausting internal appeals, Virginia provides independent review:

  • Deadline: 120 days from final internal denial
  • Cost: Free to patients
  • Process: Submit Form 216-A to [email protected]
  • Timeline: 45 days standard, 72 hours expedited
  • Decision: Binding on Aetna if overturned

Required documents for external review:

  • Completed Form 216-A
  • Copy of final denial letter
  • Insurance card copy
  • Medical records release form
  • Provider contact information
Tip: Contact the Virginia Managed Care Ombudsman at 1-877-310-6560 for free assistance with the appeals process.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Key Documentation
"Experimental/Investigational" Cite FDA approval for relapsing MS FDA label
"Step therapy not met" Document prior DMT failures Treatment records with dates, outcomes
"Not medically necessary" Provide disease activity evidence Recent MRI, EDSS scores, relapse history
"Lab requirements not met" Submit recent CBC results Lymphocyte count ≥800 cells/μL
"Wrong prescriber type" Confirm neurologist credentials NPI lookup, specialty board certification

Costs & Financial Assistance

Mavenclad's 2-year treatment course typically costs over $100,000 before insurance. Financial assistance options include:

Manufacturer Support:

  • EMD Serono Mavenclad patient support program
  • Copay assistance for eligible commercially insured patients
  • Free drug program for uninsured qualifying patients

Foundation Assistance:

  • Patient Advocate Foundation (1-800-532-5274)
  • National MS Society financial assistance programs
  • State pharmaceutical assistance programs
From our advocates: We've seen patients successfully reduce their out-of-pocket costs from thousands to under $100 per month by combining manufacturer copay cards with thorough appeals documentation. The key is applying for assistance programs while simultaneously pursuing coverage appeals—don't wait for one to resolve before starting the other.

When to Contact Virginia Regulators

Contact the Virginia State Corporation Commission Bureau of Insurance if:

  • Aetna doesn't respond to PA requests within required timeframes
  • Step therapy override requests aren't processed within 72 hours
  • Internal appeals exceed 30-45 day limits without explanation
  • You need guidance on external review eligibility

Contact Information:

  • Consumer Services: 1-800-552-7945
  • External Review: [email protected]
  • Managed Care Ombudsman: 1-877-310-6560

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Their platform helps patients and clinicians navigate complex prior authorization requirements and appeals processes for specialty medications like Mavenclad.

FAQ

How long does Aetna CVS Health prior authorization take in Virginia? Standard PA decisions are made within 72 hours of receiving complete documentation. Expedited requests (when delay would jeopardize health) are decided within 24 hours.

What if Mavenclad isn't on Aetna's formulary? You can request a formulary exception by having your neurologist document medical necessity. The request must show why preferred alternatives aren't suitable and include prior failure documentation.

Can I get expedited review if I'm having MS relapses? Yes. If your neurologist certifies that waiting for standard review could jeopardize your health, both PA decisions and appeals can be expedited to 24-72 hours in Virginia.

Does Virginia's step therapy law apply to all Aetna plans? Virginia's step therapy protections apply to state-regulated health plans. Self-funded employer plans may opt into Virginia's requirements but aren't automatically covered.

What happens if Aetna doesn't respond within Virginia's required timeframes? Under Virginia law, if insurers don't respond to step therapy override requests within 72 hours, the exception is automatically considered approved.

How much does external review cost in Virginia? External review through the Virginia State Corporation Commission is completely free for patients. There are no filing fees or administrative costs.

Can I continue my current DMT while appealing for Mavenclad? Yes. Virginia's continuity of care provisions generally allow you to continue existing therapy during appeals. Confirm this with Aetna member services for your specific situation.

What if I've tried DMTs in another state? Prior treatment history from other states counts toward step therapy requirements. Ensure your neurologist includes comprehensive records from all previous providers in the PA request.

Disclaimer: This information is for educational purposes only and doesn't constitute medical or legal advice. Coverage decisions depend on your specific plan terms and medical circumstances. Always consult your healthcare provider and insurance plan documents for personalized guidance.

For additional assistance with insurance appeals and coverage issues, Virginia residents can contact the State Corporation Commission Bureau of Insurance Consumer Services at 1-800-552-7945 or visit their website for comprehensive resources and complaint filing procedures.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.